Drug Shortage Report for MYLAN-VARDENAFIL
Report ID | 155830 |
Drug Identification Number | 02464233 |
Brand name | MYLAN-VARDENAFIL |
Common or Proper name | VARDENAFIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VARDENAFIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 BL |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-01-24 |
Estimated end date | 2022-04-26 |
Actual end date | 2022-04-25 |
Shortage status | Resolved |
Updated date | 2022-04-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-04-27 | French | Compare |
v7 | 2022-04-27 | English | Compare |
v6 | 2022-04-26 | French | Compare |
v5 | 2022-04-26 | English | Compare |
v4 | 2022-04-18 | French | Compare |
v3 | 2022-04-18 | English | Compare |
v2 | 2022-03-02 | French | Compare |
v1 | 2022-03-02 | English | Compare |
Showing 1 to 8 of 8